Cargando…
Harnessing the potential of lipid nanoparticles for the delivery of chemically modified siRNA to combat hepatic adenovirus infection
Autores principales: | Shubhra, Quazi T.H., Alam, A.K.M. Moshiul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336070/ https://www.ncbi.nlm.nih.gov/pubmed/37449043 http://dx.doi.org/10.1016/j.omtn.2023.06.005 |
Ejemplares similares
-
Lipid nanoparticle-encapsulated, chemically modified anti-adenoviral siRNAs inhibit hepatic adenovirus infection in immunosuppressed Syrian hamsters
por: Geisler, Anja, et al.
Publicado: (2023) -
Harnessing in vivo siRNA delivery for drug discovery and therapeutic development
por: Xie, Frank Y., et al.
Publicado: (2006) -
RARRES2’s impact on lipid metabolism in triple-negative breast cancer: a pathway to brain metastasis
por: Shubhra, Quazi T. H.
Publicado: (2023) -
Harnessing a Physiologic Mechanism for siRNA Delivery With Mimetic Lipoprotein Particles
por: Nakayama, Tomoko, et al.
Publicado: (2012) -
Advances in Lipid Nanoparticles for siRNA Delivery
por: Tam, Yuen Yi C., et al.
Publicado: (2013)